World Journal of Gastroenterology

Article	Citations
SARS-CoV-2 infection in people with pre-existing liver disease: Further research is warranted	351
Human immune repertoire in hepatitis B virus infection	333
Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine	243
Unresolved conundrum of the role of physical activity in irritable bowel disease: What next?	225
Colorectal motility patterns and psychiatric traits in functional constipation and constipation-predominant irritable bowel syndrome: A study from China	166
Primary hyperparathyroidism-induced acute pancreatitis in pregnancy: A systematic review with a diagnostic-treatment algorithm	152
Liquid biopsy for gastric cancer: Techniques, applications, and future directions	134
Increased systemic RNA oxidative damage and diagnostic value of RNA oxidative metabolites during Shigella flexneri-induced intestinal infection	122
Association of gene and protein expression and genetic polymorphism of CC chemokine ligand 4 in colorectal cancer	103
Comment on “Prognostic value of preoperative enhanced computed tomography as a quantitative imaging biomarker in pancreatic cancer”	101
Systemic treatment for metastatic colorectal cancer	96
Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells	96
Gastroesophageal reflux after per-oral endoscopic myotomy: Management literature	94
Establishment and validation of an adherence prediction system for lifestyle interventions in non-alcoholic fatty liver disease	90
Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report	89
Very early onset perinatal constipation: Can it be cow’s milk protein allergy?	85
Gastroesophageal reflux following peroral endoscopic myotomy for achalasia: Bumps in the road to success	84
Downregulation of TNFR2 decreases survival gene expression, promotes apoptosis and affects the cell cycle of gastric cancer cells	82
Liver parasites: A global endemic and journey from infestation to intervention	81
Amoxicillin high-dose dual therapy for Helicobacter pylori primary eradication: Proton pump inhibitor and potassium-competitive acid blocker, which’s better?	75
Link between pharyngeal acid reflux episodes and the effectiveness of proton pump inhibitor therapy	72
GLP-1, GIP/GLP-1, and GCGR/GLP-1 receptor agonists: Novel therapeutic agents for metabolic dysfunction-associated steatohepatitis	71
Role of one-step nucleic acid amplification in colorectal cancer lymph node metastases detection	68
Divergent trajectories of lean vs obese non-alcoholic steatohepatitis patients from listing to post-transplant: A retrospective cohort study	68
Three-dimensional location approach with silk thread guided hepatectomy for liver tumor	67

Perianal fistulizing Crohn’s disease: Mechanisms and treatment options focusing on cellular therapy	65
Dynamics of cytokines predicts risk of hepatocellular carcinoma among chronic hepatitis C patients after viral eradication	64
Improving early diagnosis of multiple endocrine neoplasia type 1 by assessing the gastrointestinal symptoms, hypercalcemia, and elevated serum gastrin	61
Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease	60
Prognostic impact and reasons for variability by tumor location in gastric cancer	60
Involvement of nitrergic neurons in colonic motility in a rat model of ulcerative colitis	58
Intestinal flora was associated with occurrence risk of chronic non-communicable diseases	57
Molecular mechanisms implicated in SARS-CoV-2 liver tropism	57
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	56
New treatment for gastroesophageal reflux disease: Traditional medicine, Xiaochaihu decoction	56
Abdominal cocoon in children: A case report and review of literature	55
MicroRNAs: A novel signature in the metastasis of esophageal squamous cell carcinoma	55
Endoscopic intramural cystogastrostomy for treatment of peripancreatic fluid collection: A viewpoint from a surgeon	53
Parasites of the liver: A global problem?	52
Development and validation of a nomogram for preoperative prediction of tumor deposits in colorectal cancer	52
Prostaglandin F2α synthase promotes oxaliplatin resistance in colorectal cancer through prostaglandin F2α-dependent and F2α-independent mechanism	52
Knowledge and attitudes towards the use of histological assessments in ulcerative colitis by gastroenterologists vs pathologists	51
Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis	51
Gastric pentadecapeptide BPC 157 in cytoprotection to resolve major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome	50
Contributions of the receptor for advanced glycation end products axis activation in gastric cancer	49
Factors other than fibrosis that increase measured shear wave velocity	49
Altered gut microbiota patterns in COVID-19: Markers for inflammation and disease severity	48
Role of gadoxetic acid-enhanced liver magnetic resonance imaging in the evaluation of hepatocellular carcinoma after locoregional treatment	47
New objective scoring system to clinically assess fecal incontinence	47
Modern drug discovery for inflammatory bowel disease: The role of computational methods	47
Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study	46
Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics	45
Study of the roles of caspase-3 and nuclear factor kappa B in myenteric neurons in a P2X7 receptor knockout mouse model of ulcerative colitis	44
Application of artificial intelligence in preoperative imaging of hepatocellular carcinoma: Current status and future perspectives	44
Presentation, patterns and predictive value of baseline liver tests on outcomes in COVID-19 patients without chronic liver disease	43
Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma	42
State of machine and deep learning in histopathological applications in digestive diseases	42
Autoimmune liver diseases in systemic rheumatic diseases	42
Examining dietary interventions in Crohn’s disease	42
BanXiaXieXin decoction treating gastritis mice with drug-resistant Helicobacter pylori and its mechanism	42
Non-cirrhotic hepatocellular carcinoma in chronic viral hepatitis: Current insights and advancements	42
Survival-associated alternative splicing events interact with the immune microenvironment in stomach adenocarcinoma	41
Validation of prognostic scores for predicting acute liver failure and in-hospital death in patients with dengue-induced severe hepatitis	41
Artificial intelligence system for the detection of Barrett’s esophagus	41
Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study	40
Endoscopic management of difficult common bile duct stones: Where are we now? A comprehensive review	40
Machine learning algorithms reveal gut microbiota signatures associated with chronic hepatitis B-related hepatic fibrosis	40
Fibroblast growth factor 15, induced by elevated bile acids, mediates the improvement of hepatic glucose metabolism after sleeve gastrectomy	40
Urea breath test for Helicobacter pylori infection in adult dyspeptic patients: A meta-analysis of diagnostic test accuracy	39
Artificial intelligence and inflammatory bowel disease: Where are we going?	39
Management of Flood syndrome: What can we do better?	39
Frailty in end-stage liver disease: Understanding pathophysiology, tools for assessment, and strategies for management	38
Impaired coagulation, liver dysfunction and COVID-19: Discovering an intriguing relationship	38
Machine learning identifies the risk of complications after laparoscopic radical gastrectomy for gastric cancer	38
Bridging the gap: Unveiling the crisis of physical inactivity in inflammatory bowel diseases	38

Timing of biliary decompression for acute cholangitis	37
Updates in diagnosis and management of pancreatic cysts	37
Pediatric stricturing Crohn's disease	37
Photo-activated microtubule targeting drugs: Advancing therapies for colorectal cancer	36
Bibliometrics analysis based on the Web of Science: Current trends and perspective of gastric organoid during 2010-2023	36
Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer	36
Real-time continuous image guidance for endoscopic retrograde cholangiopancreatography based on 3D/2D registration and respiratory compensation	36
Advances and challenges in peroral endoscopic myotomy: Safety, precision, and post-procedure management	36
Effectiveness and safety of tenofovir amibufenamide in chronic hepatitis B patients	36
Emerging role of non-invasive and liquid biopsy biomarkers in pancreatic cancer	36
Early genetic diagnosis of clarithromycin resistance in Helicobacter pylori	36
Hepatitis B and circadian rhythm of the liver	36
Hepatitis B virus infection in patients with Wilson disease: A large retrospective study	36
Elafibranor: A promising therapeutic approach for liver fibrosis and gut barrier dysfunction in alcohol-associated liver disease	36
Treatment of Helicobacter pylori infection in the presence of penicillin allergy	36
Minimally invasive image-guided therapy of primary and metastatic pancreatic cancer	36
Pregnancy and fetal outcomes of chronic hepatitis C mothers with viremia in China	36
Health-related quality of life after curative resection for gastric adenocarcinoma	35
Prediction of moderately severe and severe acute pancreatitis in pregnancy: Several issues	35
Epidemiology of small intestinal bacterial overgrowth	34
Antihepatoma peptide, scolopentide, derived from the centipede scolopendra subspinipes mutilans	34
Artificial intelligence in colonoscopy	34
RON in hepatobiliary and pancreatic cancers: Pathogenesis and potential therapeutic targets	34
Cellular strategies to induce immune tolerance after liver transplantation: Clinical perspectives	34
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination	34
High rate of complete histopathological response in hepatocellular carcinoma patients after combined transarterial chemoembolization and stereotactic body radiation therapy	33
Impact of baseline body mass index on the long-term prognosis of advanced hepatocellular carcinoma treated with immunotherapy	33
Emerging role of exosomes in ulcerative colitis: Targeting NOD-like receptor family pyrin domain containing 3 inflammasome	33
Distinct gut microbiomes in Thai patients with colorectal polyps	33
Artificial intelligence in small intestinal diseases: Application and prospects	33
Role of albumin-bilirubin score in non-malignant liver disease	33
Orosomucoid in liver diseases	32
Over-feeding the gut microbiome: A scoping review on health implications and therapeutic perspectives	32
Prognostic role of intestinal ultrasound in Crohn’s disease	32
Serum metabolic profiling of targeted bile acids reveals potentially novel biomarkers for primary biliary cholangitis and autoimmune hepatitis	32
Glucagon-like peptide 1 agonists are potentially useful drugs for treating metabolic dysfunction-associated steatotic liver disease	32
Neutrophil extracellular traps participate in the development of cancer-associated thrombosis in patients with gastric cancer	32
High incidence combination of multiple primary malignant tumors of the digestive system	32
Stage at diagnosis of colorectal cancer through diagnostic route: Who should be screened?	31
Evaluation of the efficacy and safety of endoscopic band ligation in the treatment of bleeding from mild to moderate gastric varices type 1	31
Outcomes of ABO-incompatible liver transplantation in end-stage liver disease patients co-infected with hepatitis B and human immunodeficiency virus	30
Secular decreasing trends in gastric cancer incidence in Taiwan: A population-based cancer registry study	30
Esophageal melanosis: Two case reports and review of literature	30
Ras-related protein Rab24 plays a predictive role in hepatocellular carcinoma and enhanced tumor proliferation	30
Artificial intelligence for hepatitis evaluation	30
Depression weights in patients with gastric cancer: Bibliometric analysis as a weapon to chart the future of research	30
Preservation of superior rectal artery in laparoscopically assisted subtotal colectomy with ileorectal anastomosis for slow transit constipation	30
Vonoprazan-amoxicillin dual regimen with Saccharomyces boulardii as a rescue therapy for Helicobacter pylori: Current perspectives and implications	30
Unveiling the anticancer effect of traditional Chinese herbal medicine	30
Current approaches to the management of jejunal variceal bleeding at the site of hepaticojejunostomy after pancreaticoduodenectomy	30
Survival benefit of younger gastric cancer patients in China and the United States: A comparative study	29
Comprehensive approach to esophageal variceal bleeding: From prevention to treatment	29
Development and validation of a predictive model for the pathological upgrading of gastric low-grade intraepithelial neoplasia	29
Modified Xiaochaihu Decoction for gastroesophageal reflux disease: A randomized double-simulation controlled trial	29
Clinical manifestations, diagnosis and long-term prognosis of adult autoimmune enteropathy: Experience from Peking Union Medical College Hospital	29
HER2-positive adenocarcinoma arising from heterotopic pancreas tissue in the duodenum: A case report	29
18β-glycyrrhetinic acid promotes gastric cancer cell autophagy and inhibits proliferation by regulating miR-328-3p/signal transducer and activator of transcription 3	28
Comparison of clinical characteristics and prognostic factors in two site-specific categories of ampullary cancer	28
Susceptibility patterns and virulence genotypes of Helicobacter pylori affecting eradication therapy outcomes among Egyptian patients with gastroduodenal diseases	28
Hepatitis B core antigen modulates exosomal miR-135a to target vesicle-associated membrane protein 2 promoting chemoresistance in hepatocellular carcinoma	28
Lipocalin-2 and intestinal diseases	28
Mixed neuroendocrine–nonneuroendocrine neoplasms of the gastrointestinal system: An update	28
Close relationship between mediators of inflammation and pancreatic cancer: Our experience	28
HP0953 hypothetical protein overexpresses and localization as virulence factor from Helicobacter pylori during infection to gastric epithelium cells	28
Hepatocardiorenal syndrome in liver cirrhosis: Recognition of a new entity?	28
Gut microbiota and female health	28
Endothelial cells and blood vessels are major targets for COVID-19-induced tissue injury and spreading to various organs	28
Revaluation of Helicobacter pylori's role in esophageal carcinoma: A call for comprehensive research	28
Environmental perspectives of COVID-19 outbreaks: A review	28
Postoperative outcomes and recurrence patterns of intermediate-stage hepatocellular carcinoma dictated by the sum of tumor size and number	27
Enteric nervous system and inflammatory bowel diseases: Correlated impacts and therapeutic approaches through the P2X7 receptor	27
Primary gastric non-Hodgkin lymphomas: Recent advances regarding disease pathogenesis and treatment	27
Gut microbiota plays a key role in the development of colorectal cancer	27
Intracellular alpha-fetoprotein mitigates hepatocyte apoptosis and necroptosis by inhibiting endoplasmic reticulum stress	27
Chinese patent medicine: Opening new perspectives for treatment of post-endoscopic submucosal dissection esophageal stricture in esophageal cancer patients	27
Fusobacterium nucleatum-induced imbalance in microbiome-derived butyric acid levels promotes the occurrence and development of colorectal cancer	27
Hepatic perivascular epithelioid cell tumor: Clinicopathological analysis of 26 cases with emphasis on disease management and prognosis	27
Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era	27
Liver histopathological lesions is severe in patients with normal alanine transaminase and low to moderate hepatitis B virus DNA replication	26
Exploring the regulatory mechanism of tRNA-derived fragments 36 in acute pancreatitis based on small RNA sequencing and experiments	26

Hepatic pseudolesions caused by alterations in intrahepatic hemodynamics	26
Cytotoxic synergism of Clostridioides difficile toxin B with proinflammatory cytokines in subjects with inflammatory bowel diseases	26
Interplay of gut microbiota, glucagon-like peptide receptor agonists, and nutrition: New frontiers in metabolic dysfunction-associated steatotic liver disease therapy	26
Current status and progress in laparoscopic surgery for gallbladder carcinoma	26
Recently acquired hepatitis C virus infection among people living with human immunodeficiency virus at a university hospital in Taiwan	26
Irreversible electroporation for the management of pancreatic cancer: Current data and future directions	26
Angiotensin-converting enzyme 2 improves liver fibrosis in mice by regulating autophagy of hepatic stellate cells	26
Challenges involved in the application of artificial intelligence in gastroenterology: The race is on!	25
Transanal eco-Doppler evaluation after hemorrhoidal artery embolization	25
Immune and metabolic cross-links in the pathogenesis of comorbid non-alcoholic fatty liver disease	25
Prevalence and clinical impact of sarcopenia in liver transplant recipients: A meta-analysis	25
Hepatocellular carcinoma progression in hepatitis B virus-related cirrhosis patients receiving nucleoside (acid) analogs therapy: A retrospective cross-sectional study	25
Impact of surgery for chronic pancreatitis on the risk of pancreatic cancer: Untying the Gordian knot	25
Assessment of liver disease in patients with chronic hepatitis C and unhealthy alcohol use	25
Pro and anti-inflammatory diets as strong epigenetic factors in inflammatory bowel disease	25
Diagnostic tools for fecal incontinence: Scoring systems are the crucial first step	25
Development of a nomogram for predicting liver transplantation prognosis in hepatocellular carcinoma	24
Liver biopsy in the post-hepatitis C virus era in Japan	24
Current status of magnetic resonance imaging radiomics in hepatocellular carcinoma: A quantitative review with Radiomics Quality Score	24
Multiple subcellular localizations and functions of protein kinase Cδ in liver cancer	24
Acute liver injury in COVID-19 patients hospitalized in the intensive care unit: Narrative review	24
Return to work in young and middle-aged colorectal cancer survivors: Factors influencing self-efficacy, fear, resilience, and financial toxicity	24
Ligation-assisted endoscopic submucosal resection following unroofing technique for small esophageal subepithelial lesions originating from the muscularis propria	24
Unraveling the therapeutic potential of Calculus Bovis in liver cancer: A novel step for targeted cancer treatment	23
Outreach onsite treatment with a simplified pangenotypic direct-acting anti-viral regimen for hepatitis C virus micro-elimination in a prison	23
Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo	23
May ChatGPT be a tool producing medical information for common inflammatory bowel disease patients’ questions? An evidence-controlled analysis	23
Clinical outcomes of lenvatinib plus transarterial chemoembolization with or without programmed death receptor-1 inhibitors in unresectable hepatocellular carcinoma	23
Optimal timing of biliary drainage based on the severity of acute cholangitis: A single-center retrospective cohort study	23
Link between childhood obesity and gut microbiota	23
Radiomics for the detection of microvascular invasion in hepatocellular carcinoma	23
Interaction between diet and genetics in patients with inflammatory bowel disease	23
Angiotensin-converting enzyme 2 alleviates liver fibrosis through the renin-angiotensin system	23
Prolonged hyperthermic intraperitoneal chemotherapy duration with 90 minutes cisplatin might increase overall survival in gastric cancer patients with peritoneal metastases	23
Important role of lymphovascular and perineural invasion in prognosis of colorectal cancer patients with N1c disease	23
Anabolic androgenic steroid-induced liver injury: An update	23
International patterns in incidence and mortality trends of pancreatic cancer in the last three decades: A joinpoint regression analysis	23
Feasibility of totally laparoscopic gastrectomy without prophylactic drains in gastric cancer patients	22
Gastric cancer incidence based on endoscopic Kyoto classification of gastritis	22
Advances in understanding and managing celiac disease: Pathophysiology and treatment strategies	22
Insights from exploring the interrelated dynamics of gallstone disease, non-alcoholic fatty liver disease, and kidney stone disease	22
Future prospect of “Gut microbiome composition can predict the response to nivolumab in advanced hepatocellular carcinoma patients”	22
Expanding indications for chronic hepatitis B treatment: Is it really desirable to treat everyone?	22
Linear endoscopic ultrasound: Current uses and future perspectives in mediastinal examination	22
Hepatic arterial infusion chemotherapy with anti-angiogenesis agents and immune checkpoint inhibitiors for unresectable hepatocellular carcinoma and meta-analysis	22
Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis	22
Successful treatment of an enormous rectal mucosa-associated lymphoid tissue lymphoma by endoscopic full-thickness resection: A case report	22
Saccharomyces cerevisiae prevents postoperative recurrence of Crohn's disease modeled by ileocecal resection in HLA-B27 transgenic rats	21
Trichostatin A augments cell migration and epithelial-mesenchymal transition in esophageal squamous cell carcinoma through BRD4/c-Myc endoplasmic reticulum-stress pathway	21
Infliximab vs adalimumab: Points to consider when selecting anti-tumor necrosis factor agents in pediatric patients with Crohn’s disease	21
Computed tomography-based radiomics combined with machine learning allows differentiation between primary intestinal lymphoma and Crohn's disease	21
Prognostic significance of hemoglobin, albumin, lymphocyte, platelet in gastrointestinal stromal tumors: A propensity matched retrospective cohort study	21
Brown slits for colorectal adenoma crypts on conventional magnifying endoscopy with narrow band imaging using the X1 system	21
Upregulated adenosine 2A receptor accelerates post-infectious irritable bowel syndrome by promoting CD4+ T cells’ T helper 17 polarization	21
Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China	21
Global research trends in the field of liver cirrhosis from 2011 to 2020: A visualised and bibliometric study	21
Clinical utility of two-dimensional shear-wave elastography in monitoring disease course in autoimmune hepatitis-primary biliary cholangitis overlap syndrome	21
Exploring non-curative endoscopic submucosal dissection: Current treatment optimization and future indication expansion	21
Locked nucleic acid real-time polymerase chain reaction method identifying two polymorphisms of hepatitis B virus genotype C2 infections, rt269L and rt269I	21
F-box only protein 2 exacerbates non-alcoholic fatty liver disease by targeting the hydroxyl CoA dehydrogenase alpha subunit	21
Guidelines on postoperative magnetic resonance imaging in patients operated for cryptoglandular anal fistula: Experience from 2404 scans	21
Regulation of transforming growth factor-β signaling as a therapeutic approach to treating colorectal cancer	21
Non-alcoholic fatty liver disease and COVID-19: Harmless companions or disease intensifier?	21
Abnormally activated wingless/integrated signaling modulates tumor-associated macrophage polarization and potentially promotes hepatocarcinoma cell growth	21
Loss of monopolar spindle-binding protein 3B expression promotes colorectal cancer malignant behaviors by activation of target of rapamycin kinase/autophagy signaling	21
Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it	21
Unlocking the potential of Calculus bovis: A breakthrough in liver cancer treatment via Wnt/β-catenin pathway modulation	21
Gut microbiota predicts the diagnosis of celiac disease in Saudi children	21
Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis	21
Sequence of events leading to primary biliary cholangitis	21
Transcription factors specificity protein and nuclear receptor 4A1 in pancreatic cancer	21
Clinical features, diagnosis, and treatment of Peutz-Jeghers syndrome: Experience with 566 Chinese cases	20
Comments on “Effect of type 2 diabetes mellitus in the prognosis of acute-on-chronic liver failure patients in China”	20
Use of shear wave elastography for the diagnosis and follow-up of biliary atresia: A meta-analysis	20
Alleviation of acute pancreatitis-associated lung injury by inhibiting the p38 mitogen-activated protein kinase pathway in pulmonary microvascular endothelial cells	20
Nuclear factor erythroid 2-related factor 2-mediated signaling and metabolic associated fatty liver disease	20
N6-methyladenosine-modified long non-coding RNA KIF9-AS1 promotes stemness and sorafenib resistance in hepatocellular carcinoma by upregulating SHOX2 expression	20
Long noncoding RNA TNFRSF10A-AS1 promotes colorectal cancer through upregulation of HuR	20
Syngeneic implantation of mouse hepatic progenitor cell-derived three-dimensional liver tissue with dense collagen fibrils	20
Mechanisms of ductular reaction in non-alcoholic steatohepatitis	20
Comment on review article: Chronic hepatitis C virus infection cascade of care in pediatric patients	20
Hypoxia inducible factor 1α promotes interleukin-1 receptor antagonist expression during hepatic ischemia-reperfusion injury	20
Multi-clustering study on the association between human leukocyte antigen-DP-DQ and hepatitis B virus-related hepatocellular carcinoma and cirrhosis in Viet Nam	20
Genetic intersection of human leukocyte antigen-DP/DQ and hepatitis B virus-related liver disease: Insights from a multi-clustering study	20
Viral hepatitis: Milestones, unresolved issues, and future goals	20
Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease	20
Interaction between gut microbiota and COVID-19 and its vaccines	20
Update on endoscopic ultrasound-guided liver biopsy	20
Neurological manifestations of hepatitis E virus infection: An overview	20
Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study	20
Emerging applications of radiomics in rectal cancer: State of the art and future perspectives	20
New prognostic model for patients with advanced gastric cancer: Fluoropyrimidine/platinum doublet for first-line chemotherapy	20
Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases	19
Critical assessment of the reported bidirectional associations between gallstone, non-alcoholic fatty liver, and kidney stone diseases	19
Diagnosis, treatment, and current concepts in the endoscopic management of gastroenteropancreatic neuroendocrine neoplasms	19